dermatomyositis/мучнина

Веза се чува у привремену меморију

Изаберите тип сортирања

12 резултати

Dermatomyositis with renal infarction: a case report and literature review.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Renal infarction is a rare clinical entity that is not easily detected by low-sensitivity ultrasound. We herein report a case of dermatomyositis with renal infarction detected during corticosteroid therapy. The patient was followed up for 18 months. A woman who was clinically diagnosed with

Acute acalculous cholecystitis in a patient with juvenile dermatomyositis.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Juvenile dermatomyositis (JDM) is a rare autoimmune disease, characterised by a systemic capillary vasculopathy that typically affects skin and muscle. Gastrointestinal involvement is relatively rare. We report the case of an 11-year-old girl admitted for investigation of skin rash, progressive

Recurrent pneumatosis intestinalis in a patient with dermatomyositis.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

A 51-year-old woman with dermatomyositis (DM) on chronic immunosuppressive therapy was hospitalised for evaluation of haematuria. Surprisingly, abdominal imaging demonstrated pneumoperitoneum and pneumatosis intestinalis (PI). Her abdominal examination and white cell count were normal, but she

Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The conditions of three children with dermatomyositis and one child with polymyositis were treated for nine to 31 months with combined prednisone and intravenous methotrexate (1 mg/kg/wk) when prednisone alone was ineffective in controlling the disease or when there were substantial steroid-related

Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Two children with chronic dermatomyositis who were treated with intravenous immunoglobulin (IVIG) for 28 and 12 months, respectively, are reported. Both patients had received prednisone and immunosuppressive agents prior to IVIG treatments and had experienced significant side effects. Strength and

Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND High-dose intravenous immune globulins (IVIg) are frequently used in refractory juvenile dermatomyositis (JDM) but are often poorly tolerated. High-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins (fSCIg) allow the administration of much higher doses of

Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Rationale: Antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive clinically amyopathic dermatomyositis (cADM) is frequently complicated with interstitial lung disease (ILD) and has a poor prognosis. Although the

Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Dermatomyositis is associated with malignancy in approximately 20-25% of cases. The most common associated cancers are ovarian, lung, pancreatic, stomach, colon and non-Hodgkin's lymphoma. Nasopharyngeal cancer is not common in the Caucasian population; however, there is a much higher incidence in

Eosinophilic gastroenteritis associated with systemic lupus erythematosus.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Eosinophilic gastroenteritis is an uncommon disease with an obscure etiology, although associations with allergy, the idiopathic hypereosinophilic syndrome, and connective tissue disease have been reported. We present the case of a 37-year-old woman with a history of idiopathic thrombocytopenic

[Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To report the efficacy and adverse events with the use of anti-TNFalpha agents in pediatric patients with rheumatic diseases. METHODS Retrospective, observational clinical case series of patients with rheumatic diseases refractory to the conventional treatment. Infliximab and etanercept

Cyclophosphamide for connective tissue disease-associated interstitial lung disease.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Approximately one-third of individuals with interstitial lung disease (ILD) have associated connective tissue disease (CTD). The connective tissue disorders most commonly associated with ILD include scleroderma/systemic sclerosis (SSc), rheumatoid arthritis, polymyositis/dermatomyositis,

Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current view.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Intravenous immunoglobulins (IVIgs) exert a variety of immunomodulating activities and are, therefore, increasingly being used for the treatment of immune-mediated as well as autoimmune diseases. There is also accumulating evidence that high-dose IVIg (hdIVIg) is highly efficacious in the treatment

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима